Reviva Pharmaceuticals
$0.29
157
-$0.01-1.78% Today
Statistics
Day High
0.3
Day Low
0.28
52W High
2.15
52W Low
0.25
Volume
577,678
Avg. Volume
5,379,447
Mkt Cap
33.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
23MarExpected
Expected EPS
-0.054286
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-59.84MNet Income
Analyst Ratings
$3.33Average Price Target
The highest estimate is 7.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 83%
Hold 17%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RVPH. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Alkermes
ALKS
Mkt Cap5.07B
Acadia Pharmaceuticals
ACAD
Mkt Cap3.83B
BridgeBio Pharma
BBIO
Mkt Cap12.07B
Insmed
INSM
Mkt Cap40.44B
Axsome Therapeutics
AXSM
Mkt Cap6.74B
Biogen
BIIB
Mkt Cap22.63B
AMGEN
AMGN
Mkt Cap160.66B
About
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.
Show more...
CEO
Dr. Laxminarayan Bhat Ph.D.
Employees
14
Country
US
ISIN
US76152G1004
Listings
0 Comments
Share your thoughts
FAQ
What is Reviva Pharmaceuticals stock price today?▼
The current price of RVPH is $0.29 USD — it has decreased by -1.78% in the past 24 hours. Watch Reviva Pharmaceuticals stock price performance more closely on the chart.
What is Reviva Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Reviva Pharmaceuticals stocks are traded under the ticker RVPH.
Is Reviva Pharmaceuticals stock price growing?▼
RVPH stock has fallen by -6.37% compared to the previous week, the month change is a -8.52% fall, over the last year Reviva Pharmaceuticals has showed a -85.75% decrease.
What is Reviva Pharmaceuticals market cap?▼
Today Reviva Pharmaceuticals has the market capitalization of 33.07M
When is the next Reviva Pharmaceuticals earnings date?▼
Reviva Pharmaceuticals is going to release the next earnings report on March 23, 2026.
What were Reviva Pharmaceuticals earnings last quarter?▼
RVPH earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.09 USD resulting in a +36.66% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Reviva Pharmaceuticals revenue for the last year?▼
Reviva Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Reviva Pharmaceuticals net income for the last year?▼
RVPH net income for the last year is -59.84M USD.
How many employees does Reviva Pharmaceuticals have?▼
As of February 03, 2026, the company has 14 employees.
In which sector is Reviva Pharmaceuticals located?▼
Reviva Pharmaceuticals operates in the Health Care sector.
When did Reviva Pharmaceuticals complete a stock split?▼
Reviva Pharmaceuticals has not had any recent stock splits.
Where is Reviva Pharmaceuticals headquartered?▼
Reviva Pharmaceuticals is headquartered in Cupertino, US.